Predictors of Success of Immediate Tracheal Extubation in Living Donor Liver Transplantation Recipients

Abstract

Liver transplantation is currently the treatment of choice for patients with end stage liver disease or liver failure for which no other treatment modality is available. To this day, living-donor liver transplant remains the only possible option for patients with end stage liver disease in Egypt as cadaveric or deceased liver donation has not yet been implemented although legalized since 2010. Patients should be considered for LT if they have evidence of fulminant hepatic failure, a life-threatening systemic complication of a liver disease or a liver-based metabolic defect or, more commonly, cirrhosis with complications such as hepatic encephalopathy, ascites, hepatocellular carcinoma, hepatorenal syndrome, or bleeding caused by portal hypertension.